The latest featured news from Adrenal World News
In this episode, Dr. Mario Maldonado from Recordati Rare Diseases discusses recent advances in endocrinology, focusing on hypercortisolism, diagnostic challenges, and innovative treatments. He shares insights from clinical studies and the future of AI in disease management. We touched on the importance of increased awareness of milder forms of hypercortisolism, the challenges of diagnosing subtle endocrine disorders, and the critical impact of AI on data analysis and patient identification.
From Lewis Blevins, M.D. Medical Director of the California Center for Pituitary Disorders at UCSF and PWN co-founder – a summary of an important study by Dr. Marta Araujo-Castro and others (J Clin Endocrinol Metab 111:2180-2189, 2026) recently published a manuscript titled “International real-world study on osilodrostat efficacy and safety in adrenal Cushing syndrome.”
There is a particular kind of moment in medicine when a field discovers that one of its settled assumptions was simply wrong. It rarely arrives with drama. More often it arrives as a number on a slide. I ran into John Hilton, Vice President of Marketing at Corcept Therapeutics, on the floor at ENDO 2026 in Chicago and here’s our short chat. We talked about where cortisol science is heading. We focused on the number nobody predicted.
Interviews, expert presentations, and the latest treatment data — all from this year’s largest endocrinology meeting. From J D Faccinetti co-founder – The annual international endocrine conference ENDO 2026, which just ended in Chicago, yielded a
Once-daily evening osilodrostat may restore circadian cortisol rhythm and improve sleep From Lewis S. Blevins Jr., MD – PWN co-founder and medical director of the California Center for Pituitary Disorders at UCSF – Chronotherapy is a
From Lewis S. Blevins, Jr. MD – The practice of medicine has undergone considerable change since I graduated from medical school in 1987. Some of the changes have been revolutionary in response to advances in
From J D Faccinetti – PWN co-founder and chief editor – Hypercortisolism, also known as Cushing’s syndrome – not to be confused with Cushing’s disease (more on that below), is far more common in people
An important note by Dr. Lewis S. Blevins, Jr., Medical Director, California Center for Pituitary Disorder and Co-Founder, Pituitary World News. I’m losing my patience with insurance companies and pharmacy benefit managers. They are destroying
Genetics of Cortisol-Producing Adrenal Adenomas: Adrenal adenomas have been demonstrated to arise from the same types of genetic mutations we have discussed in articles on adrenal hyperplasia. Most of these are likely somatic mutations leading
From Lewis Blevins MD, Adrenal World News cofounder, medical director of the California Center for Pituitary disorders and professor of neurological surgery at UCSF – I always suggest that a diagnosis of PsuedoCushing’s syndrome be
From the desk of Lewis Blevins, MD, AWN cofounder – I have a vague recollection of considering the possibility of the coexistence of primary aldosteronism and hypercortisolism in adrenal hyperplasia during my fellowship in Endocrinology
In this recent Medscape InDiscussion podcast Dr. Marwah Abdalla welcomes PWN’s Dr. Lewis Blevins to talk about secondary hypertension. This episode focuses on Cushing syndrome, an often overlooked cause of secondary hypertension. We’ll discuss why